| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |